An update on the medical treatment of Graves' hyperthyroidism

Academic Psychiatry

Volumn 37, Issue 11, 2014, Pages 1041-1048

  Marinò, Michele ^a,b   Latrofa, Francesco ^a,b   Menconi, Francesca ^a,b   Chiovato, Luca ^c,d   Vitti, Paolo ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d IRCCS   (Italy)

Author keywords

Graves' disease; Hyperthyroidism; Methimazole; Propylthiouracil; Thyrotoxicosis

Indexed keywords

ANTITHYROID AGENT; PROPYLTHIOURACIL; THIAMAZOLE;

ANIMAL; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; TREATMENT OUTCOME;

ANIMALS; ANTITHYROID AGENTS; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; METHIMAZOLE; PROPYLTHIOURACIL; TREATMENT OUTCOME;

EID: 84910635512     PISSN: 10429670     EISSN: 15457230     Source Type: Journal    
DOI: 10.1007/s40618-014-0136-z     Document Type: Review

References (58)

1. Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN (2011) Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 21:593-646
2. Astwood EB (1943) Treatment of of hyperthyroidism with thiourea and thiouracil. JAMA 122:78
3. Cooper DS (2005) Antithyroid drugs. N Engl J Med 352:905-917
4. Wartofsky L, Glinoer D, Solomon B, Lagasse R (1991) Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan and the United States. Thyroid 1:129-135
5. Emiliano AB, Governale L, Parks M, Cooper DS (2010) Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008. J Clin Endocrinol Metab 95:2227-2233
6. Glinoer D, Cooper DS (2012) The propylthiouracil dilemma. Curr Opin Endocrinol Diabet Obes 19:402-407
7. Bahn RS, Burch HS, Cooper DS, Garber JR, Greenlee CM, Klein IL, Laurberg P, McDougall IR, Rivkees SA, Ross D, Sosa JA, Stan MN (2009) The role of propylthiouracil in the management of Graves' disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid 19:673-674
8. Reinwein D, Benker G, Lazarus JH, Alexander WD (1993) A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment. J Clin Endocrinol Metab 76:1516-1521
9. Konishi T, Okamoto Y, Ueda M, Fukuda Y, Harusato I, Tsukamoto Y, Hamada N (2011) Drug discontinuation after treatment with minimum maintenance dose of an antithyroid drug in Graves' disease: a retrospective study on effects of treatment duration with minimum maintenance dose on lasting remission. Endocr J 58:95-100
10. Vitti P, Rago T, Chiovato L, Pallini S, Santini F, Fiore E, Rocchi R, Martino E, Pinchera A (1997) Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid 7:369-375
11. Kaguelidou F, Alberti C, Castanet M, Guitteny MA, Czernichow P, Léger J (2008) Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment. J Clin Endocrinol Metab 93:3817-3826
12. Wartofsky L (1973) Low remission after therapy for Graves' disease. Possible relation of dietary iodine with antithyroid therapy results. JAMA 226:1083-1088
13. Solomon BL, Evaul JE, Burman KD, Wartofsky L (1987) Remission rates with antithyroid drug therapy: continuing influence of iodine intake? Ann Intern Med 107:510-512
14. Barbesino G, Tomer Y (2013) Clinical utility of TSH receptor antibodies. J Clin Endocrinol Metab 98:2247-2255
15. Lamberg BA, Salmi J, Wagar G, Makinen T (1981) Spontaneous hypothyroidism after antithyroid treatment of hyperthyroid Graves' disease. J Endocrinol Invest 4(3):99-402
16. Feldt-Rasmussen U, Schleusener H, Carayon P (1994) Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. J Clin Endocrinol Metab 78:98-102
17. Tripodi PF, Ruggeri RM, Campennì A, Cucinotta M, Mirto A, Lo Gullo R, Baldari S, Trimarchi F, Cucinotta D, Russo GT (2008) Central nervous system vasculitis after starting methimazole in a woman with Graves' disease. Thyroid 18:1011-1013
18. Ruggeri RM, Imbesi S, Saitta S, Campennì A, Cannavò S, Trimarchi F, Gangemi S (2013) Chronic idiopathic urticaria and Graves' disease. J Endocrinol Invest 36:531-536
19. Weetman AP, McGregor AM, Hall R (1984) Evidence for an effect of antithyroid drugs on the natural history of Graves' disease. Clin Endocrinol 21:163-172
20. Marcocci C, Marinò M (2005) Thyroid directed antibodies. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's the thyroid: a fundamental and clinical text, 9th edition. Lippincott, Williams & Wilkins, Philadelphia, pp 360-372
21. Weetman AP, McGregor AP, Hall R (1983) Methimazole inhibits thyroid autoantibody production by an action on accessory cells. Clin Immunol Immunopathol 28:39-45
22. Weiss I, Davies TF (1981) Inhibition of immunoglobulin-secreting cells by antithyroid drugs. J Clin Endocrinol Metab 53:1223-1228
23. Rennie DP, McGregor AM, Keast D, Weetman AP, Foord SM, Dieguez C, Williams ED, Hall R (1983) The influence of methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat. Endocrinology 112:326-330
24. Wenzel KW, Lente JR (1984) Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs. J Clin Endocrinol Metab 58:62-69
25. Nakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A, Hamada N (2007) Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab 92:2157-2162
26. Li D, Pei H, Li X, Liu X, Li X, Xie Y (2012) Short-term effects of combined treatment with potassium bromide and methimazole in patients with Graves' disease. J Endocrinol Invest 35:971-974
27. Hashizume K, Ichikawa K, Sakurai A, Suzuki S, Takeda T, Kobayashi M, Miyamoto T, Arai M, Nagasawa T (1991) Administration of thyroxine in treated Graves' disease - effects on the level of antibodies to thyroid stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med 324:947-953
28. Romaldini JH, Bromberg N, Werner RS, Tanaka LM, Rodrigues HF, Werner MC, Farah CS, Reis LC (1983) Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism. J Clin Endocrinol Metab 57:563-570
29. Tamai H, Hayaki I, Kawai K, Komaki G, Matsubayashi S, Kuma K, Kumagai LF, Nagataki S (1995) Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients. J Clin Endocrinol Metab 80:1481-1484
30. Rittmaster RS, Zwicker H, Abbott EC, Douglas R, Givner ML, Gupta MK, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE (1996) Effect of methimazole with or without exogenous l-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease. J Clin Endocrinol Metab 81:3283-3288
31. Rizvi A, Crapo LM (1996) Failure of thyroxine therapy for Graves' disease (letter). Ann Intern Med 124:694
32. Rittmaster RS, Abbott EC, Douglas R, Givner ML, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE (1998) Effect of methimazole, with or without l-thyroxine, on remission rates in Graves' disease. J Clin Endocrinol Metab 83:814-818
33. Emerson CH, Anderson AJ, Howard WJ, Utiger RD (1975) Serum thyroxine and triiodothyronine concentrations during iodide treatment of hyperthyroidism. J Clin Endocrinol Metab 40:33-36
34. Marigold JH, Morgan AK, Earle DJ, Young AE, Croft DN (1985) Lugol's iodine: its effect on thyroid blood flow in patients with thyrotoxicosis. Br J Surg 72:45-47
35. Chang DC, Wheeler MH, Woodcock JP, Curley I, Lazarus JR, Fung H, John R, Hall R, McGregor AM (1987) The effect of preoperative Lugol's iodine on thyroid blood flow in patients with Graves' hyperthyroidism. Surgery 102:1055-1061
36. Laurberg P, Boye N (1987) Inhibitory effect of various radiographic contrast agents on secretion of thyroxine by the dog thyroid and on peripheral and thyroidal deiodination of thyroxine to tri-iodothyronine. J Endocrinol 112:387-390
37. DeGroot LJ, Buhler U (1971) Effect of perchlorate and methimazole on iodine metabolism. Acta Endocrinol (Copenh) 68:696-706
38. Barzilai D, Sheinfeld M (1966) Fatal complications following use of potassium perchlorate in thyrotoxicosis. Report of two cases and a review of the literature. Isr J Med Sci 2:453-456
39. Bogazzi F, Giovannetti C, Fessehatsion R, Tanda ML, Campomori A, Compri E, Rossi G, Ceccarelli C, Vitti P, Pinchera A, Bartalena L, Martino E (2010) Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal. J Clin Endocrinol Metab 95:201-208
40. Martin NM, Patel M, Nijher GM, Misra S, Murphy E, Meeran K (2012) Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease. Clin Endocrinol (Oxf) 77:621-627
41. Henderson JM, Portmann L, Van Melle G, Haller E, Ghika JA (1997) Propranolol as an adjunct therapy for hyperthyroid tremor. Eur Neurol 37:182-185
42. Wiersinga WM (1991) Propranolol and thyroid hormone metabolism. Thyroid 1:273-277
43. Neumann S, Eliseeva E, McCoy JG, Napolitano G, Giuliani C, Monaco F, Huang W, Gershengorn MC (2011) A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptor. J Clin Endocrinol Metab 96:548-554
44. Ueki I, Abiru N, Kobayashi M, Nakahara M, Ichikawa T, Eguchi K, Nagayama Y (2011) B cell-targeted therapy with anti-CD20 monoclonal antibody in a mouse model of Graves' hyperthyroidism. Clin Exp Immunol 163:309-317
45. Heemstra KA, Toes RE, Sepers J, Pereira AM, Corssmit EP, Huizinga TW, Romijn JA, Smit JW (2008) Rituximab in relapsing Graves' disease, a phase II study. Eur J Endocrinol 159:609-615
46. Marcocci C, Kahaly GJ, Krassas GE, Bartalena L, Prummel M, Stahl M, Altea MA, Nardi M, Pitz S, Boboridis K, Sivelli P, von Arx G, Mourits MP, Baldeschi L, Bencivelli W, Wiersinga W (2011) Selenium and the course of mild Graves' orbitopathy. N Engl J Med 364:1920-1931
47. Piantanida E, Tanda ML, Lai A, Sassi L, Bartalena L (2013) Prevalence and natural history of Graves' orbitopathy in the XXI century. J Endocrinol Invest 36:444-449
48. Bülow Pedersen I, Knudsen N, Carlé A, Schomburg L, Köhrle J, Jørgensen T, Rasmussen LB, Ovesen L, Laurberg P (2013) Serum selenium is low in newly diagnosed Graves' disease: a population-based study. Clin Endocrinol (Oxf) 79:584-590
49. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, Nixon A, Pearce EN, Soldin OP, Sullivan S, Wiersinga W (2011) Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21:1081-1125
50. Lazarus JH (2012) Antithyroid drug treatment in pregnancy. J Clin Endocrinol Metab 97:2289-2291
51. De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, Eastman CJ, Lazarus JH, Luton D, Mandel SJ, Mestman J, Rovet J, Sullivan S (2012) Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 97:2543-2565
52. Marchant B, Brownlie BE, Hart DM, Horton PW, Alexander WD (1977) The placental transfer of propylthiouracil, methimazole and carbimazole. J Clin Endocrinol Metab 45:1187-1193
53. Yoshihara A, Noh J, Yamaguchi T, Ohye H, Sato S, Sekiya K, Kosuga Y, Suzuki M, Matsumoto M, Kunii Y, Watanabe N, Mukasa K, Ito K, Ito K (2012) Treatment of Graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab 97:2396-2403
54. Ribuffo D, Costantini M, Gullo P, Houseman ND, Taylor GI (2003) Aplasia cutis congenita of the scalp, the skull, and the dura. Scand J Plast Reconstr Surg Hand Surg 37:176-180
55. Santini F, Chiovato L, Ghirri P, Lapi P, Mammoli C, Montanelli L, Scartabelli G, Ceccarini G, Coccoli L, Chopra IJ, Boldrini A, Pinchera A (1999) Serum iodothyronines in the human fetus and the newborn: evidence for an important role of placenta in fetal thyroid hormone homeostasis. J Clin Endocrinol Metab 84:493-498
56. Rotondi M, Cappelli C, Pirali B, Pirola I, Magri F, Fonte R, Castellano M, Rosei EA, Chiovato L (2008) The effect of pregnancy on subsequent relapse from Graves' disease following a successful course of anti-thyroid drug therapy. J Clin Endocrinol Metab 93:3985-3988
57. Azizi F, Amouzegar A (2011) Management of hyperthyroidism during pregnancy and lactation. Eur J Endocrinol 164:871-876
58. Zakarija M, McKenzie JM (1983) Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab 57:1036-1040